共 166 条
[1]
Gnanapragasam VJ(2022)Urinary symptoms and prostate cancer—the misconception that may be preventing earlier presentation and better survival outcomes BMC Med 83 599-605
[2]
Greenberg D(2018)Rapid Recommendations: Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline BMJ 48 234-239
[3]
Burnet N(2022)Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review Prostate Cancer Prostatic Dis 448 220-227
[4]
Tikkinen KAO(2014)Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold Urology 13 1-10
[5]
Dahm P(1996)Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study Urology 123 487-494
[6]
Lytvyn L(2015)Total, free, and complexed prostate-specific antigen levels among US men, 2007–2010 Clin Chim Acta 69 1473-1480
[7]
Barlow M(2015)Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010 BMC Med 81 1071-1077
[8]
Down L(2022)Differences in cancer incidence by broad ethnic group in England, 2013–2017 Br J Cancer 48 1740-1740g
[9]
Mounce LTA(2020)Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment Br J Cancer 46 1093-1093i
[10]
Merriel SWD(2020)prostate cancer incidence and survival, by stage and race/ethnicity - United States, 2001–2017 MMWR Morb Mortal Wkly Rep 49 16-16h